Structure | Cat No. | Product Name | CAS No. | Product Description |
---|---|---|---|---|
![]() |
V58342 | Anti-inflammatory agent 19 | 2873386-63-9 | Anti-inflammatory agent 19 (compound 2b) showed NO inhibitory activity with IC50 of 36.00 μM. |
![]() |
V62178 | Anti-inflammatory agent 32 | 2577388-38-4 | Anti-inflammatory agent 32 (compound C3) has antioxidant and anti-inflammatory activities. |
![]() |
V58871 | Anti-inflammatory agent 34 | 867301-81-3 | anti~inflammatory agent 34 (Compound IVf) is an orally bioactive anti~inflammatory pain-relief agent. |
![]() |
V57673 | Anti-inflammatory agent 36 | 2293951-01-4 | anti~inflammatory agent 36 is an anti~inflammatory agent. |
![]() |
V58171 | Anti-inflammatory agent 49 | 851471-44-8 | Anti-inflammatory agent 49 (compound SC9) is an inhibitor (blocker/antagonist) of Drp1-Fis1 interaction and can alleviate Fis1-mediated mitochondrial dysfunction. |
![]() |
V61009 | Anti-inflammatory agent 63 | 2347694-79-3 | Anti-inflammatory agent 63 is an anti-inflammatory agent with optimal inhibitory effect against lipopolysaccharide (LPS)-induced nitric oxide (NO) production in RAW264.7 cells (EC50 = 5.33±0.57 μM). |
![]() |
V58841 | Anti-osteoporosis agent-3 | 2944463-16-3 | Anti-osteoporosis agent-3 (Compound 11), a PMSan analogue, is an anti-osteoporosis agent. |
![]() |
V60524 | Anti-osteoporosis agent-7 | 445254-59-1 | Anti-osteoporosis agent-7 (Compound 133) is a potential anti-osteoporosis agent showing high inhibition of osteoclast formation. |
![]() |
V57132 | Anti-ToCV agent 1 | 2848583-24-2 | Anti-ToCV agent 1 can be used as a potential anti-ToCV active molecule. |
![]() |
V58584 | Anti-TSWV agent 1 | 2763371-23-7 | Anti-TSWV agent 1 has excellent inactivating activity against tomato spotted wilt virus (TSWV), with EC50 of 144 μg/mL. |
![]() |
V58346 | Anticancer agent 100 | 2914922-73-7 | anti-cancer compound 100 is a tetracaine analogue with anti-cancer effect and may be used in cancer-related research. |
![]() |
V59142 | Anticancer agent 101 | 2914922-80-6 | anti-cancer compound 101 is an analogue of tetracaine. |
![]() |
V57690 | Anticancer agent 103 | 2914922-78-2 | anti-cancer compound 103 (Compound 2k) is a potent anti-cancer compound. |
![]() |
V57663 | Anticancer agent 107 | 2397573-96-3 | Anticancer agent 107 (Compd 11jc) has significant anti-tumor activity and could be utilized as an anti-cancer agent to study lung metastasis melanoma. |
![]() |
V57805 | Anticancer agent 112 | 2495321-37-2 | anti-cancer compound 112 is a potent anti-cancer compound used in cancer-related research, disclosed in patent WO2020198567. |
![]() |
V57789 | Anticancer agent 113 | 2495323-17-4 | anti-cancer compound 113 is a compound with anti-cancer effect. |
![]() |
V59157 | Anticancer agent 12 | 2832055-89-5 | anti-cancer compound 12 is surprisingly devoid of hepatotoxicity while maintaining cytotoxic activity against malignant cells. |
![]() |
V57086 | Anticancer agent 13 | 38116-01-7 | anti-cancer compound 13 is an anti-cancer compound developed from dicarboxylic acids and amines. |
![]() |
V57613 | Anticancer agent 131 | 2864443-47-8 | HCT-116-IN-1 is a γ-lactam fused pyridone analogue with anti-cancer activity and shows high cytotoxic effect against HCT116 cells with IC50 of 5.59 μM. |
![]() |
V60985 | Anticancer agent 16 | 2761205-38-1 | Anticancer agent 16 showed good cytotoxic activity against HCT-116, NCI-H460 and SKOV3 cell lines, with IC50 of 8.55 μM, 5.41 μM and 6.4 μM respectively. |